Clinical Trial

Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

Study acronym: Cybertaxcis II
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a monocentric, non-randomized, open-label, superiority phase II clinical investigation evaluating the efficacy of additional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in patients with locally advanced non-small cell lung carcinoma (NSCLC), with an interim analysis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-10-03; most recent amendment 2025-12-30.
Status change: Not Yet Recruiting → Recruiting 2025-06-19
Trial Details
NCT Number NCT06627738
Lead Sponsor Centre Antoine Lacassagne
Conditions Carcinoma, Non-Small-Cell Lung
Enrollment 42 participants
Start Date 2025-06-10
Primary Completion 2034-02 (estimated)
Study Completion 2034-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-05